流感病毒研究现状与进展

doi:10.3969/j.issn.1673-8640.2020.012.027

检验医学 ›› 2020, Vol. 35 ›› Issue (12): 1315-1319.DOI: 10.3969/j.issn.1673-8640.2020.012.027

流感病毒研究现状与进展

马洲¹, 关明², 邢志芳², 曹国君¹

1.复旦大学附属华山医院北院检验科,上海 201907
2.复旦大学附属华山医院检验医学科,上海 200040

收稿日期:2020-03-02 出版日期:2020-12-30 发布日期:2020-12-31
作者简介:null
通信作者：曹国君,联系电话：021-66895999。
作者简介：马洲,女,1997年生,学士,检验技师,主要从事病原微生物感染的早期检测研究。
基金资助:
上海市“医苑新星”青年医学人才培养资助计划（青年医学人才类——临床检验项目）;上海市科学技术委员会“科技创新行动计划”生物医药科技支撑专项（20S31902700）;中国博士后科学基金项目（2020T130091ZX、2020M681733）

Research status and progress of influenza viruses

MA Zhou¹, GUAN Ming², XING Zhifang², CAO Guojun¹

1. Department of Clinical Laboratory,North Campus,Huashan Hospital,Fudan University,Shanghai 200040,China
2. Department of Clinical Laboratory,Huashan Hospital,Fudan University,Shanghai 200040,China

Received:2020-03-02 Online:2020-12-30 Published:2020-12-31

摘要/Abstract

摘要：

流行性感冒是一种由流感病毒引发的急性呼吸道传染病,春、秋季节高发。由于流感病毒基因容易发生变异,病毒基因重组过程复杂且无法预测,易突变成新的流感病毒变异株。此外,禽流感病毒（AIV）频繁地从禽类跨物种直接感染人类,甚至曾经引发全球范围内的大流行,为人类健康和公共卫生安全埋下了巨大隐患。近年来,针对流感病毒的研究已取得了诸多成果。文章从流感病毒的病原学、临床表现与传播方式、致病机制、检测方法和治疗方案等方面进行综述。

关键词: 流感病毒, 病原学, 临床表现与传播方式, 致病机制, 检测方法, 治疗方案

Abstract:

Influenza is an acute respiratory infectious disease caused by influenza viruses,which occurs frequently in spring and autumn. Because of the gene variations and unpredictable recombination of influenza viruses,it is easy to mutate to produce a new type of influenza virus variant. In addition,avian influenza viruses（AIV） frequently infect human directly from poultry cross species,even have caused a global pandemic,laying a hidden danger for human health and public health safety. In the recent years,much progress has been made in the research of influenza viruses. This review focuses on the etiology,clinical symptoms and mode of transmission,pathogenic mechanism,detection methods and treatment plan of influenza viruses.

Key words: Influenza virus, Etiology, Clinical symptom and mode of transmission, Pathogenic mechanism, Detection method, Treatment plan

中图分类号:

R373.1

马洲, 关明, 邢志芳, 曹国君. 流感病毒研究现状与进展[J]. 检验医学, 2020, 35(12): 1315-1319.

MA Zhou, GUAN Ming, XING Zhifang, CAO Guojun. Research status and progress of influenza viruses[J]. Laboratory Medicine, 2020, 35(12): 1315-1319.

参考文献 37

[1]	JENNINGS L,HUANG Q S,BARR I,et al.Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region[J]. Influenza Other Respir Viruses,2018,12(3):383-411.
[2]	闫若潜,杜向党. 流感病毒基因组结构及其编码蛋白研究进展[J]. 动物医学进展,2004,25(1):32-35.
[3]	房师松,王昕. 甲型流感病毒宿主特异性与适应性进化[J]. 国际病毒学杂志,2019,26(6):426-430.
[4]	ZHANG R,CHEN T,OU X,et al.Clinical,epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus[J]. Infect Genet Evol,2016,40:236-242.
[5]	TRAN D,VAUDRY W,MOORE D,et al.Hospitalization for influenza A versus B[J]. Pediatrics,2016,138(3):e20154643.
[6]	ZHAI S L,ZHANG H,CHEN S N,et al.Influenza D virus in animal species in Guangdong province,southern China[J]. Emerg Infect Dis,2017,23(8):1392-1396.
[7]	钟慧君,李慧锦,杨勇. 87例流感合并肺炎支原体感染患儿临床特征[J]. 中国感染控制杂志,2019,18(12):1154-1158.
[8]	LI S,LIU S S,ZHU A Q,et al.The mortality burden of influenza in China:a systematic review[J]. Zhonghua Yu Fang Yi Xue Za Zhi,2019,53(10):1049-1055.
[9]	LIU S,SHA J,YU Z,et al.Avian influenza virus in pregnancy[J]. Rev Med Virol,2016,26(4):268-284.
[10]	BELSER J A,LASH R R,GARG S,et al.The eyes have it:influenza virus infection beyond the respiratory tract[J]. Lancet Infect Dis,2018,18(7):e220-e227.
[11]	PETERANDERL C,HEROLD S,SCHMOLDT C.Human influenza virus infections[J]. Semin Respir Crit Care Med,2016,37(4):487-500.
[12]	DHARMAPALAN D.Influenza[J]. Indian J Pediatr,2020,87:828-832.
[13]	WANG X,SUN Q,YE Z,et al.Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus[J]. Exp Ther Med,2016,12(4):2439-2446.
[14]	KIM K S,JUNG H,SHIN I K,et al.Induction of interleukin-1 beta(IL-1β) is a critical component of lung inflammation during influenza A(H1N1) virus infection[J]. J Med Virol,2015,87(7):1104-1112.
[15]	CARLIN A F,PLUMMER E M,VIZCARRA E A,et al.An IRF-3-,IRF-5-,and IRF-7-independent pathway of dengue viral resistance utilizes IRF-1 to stimulate type Ⅰ and Ⅱ interferon responses[J]. Cell Rep,2017,21(6):1600-1612.
[16]	HARADA K.Sclerosing and obstructive cholangiopathy in biliary atresia:mechanisms and association with biliary innate immunity[J]. Pediatr Surg Int,2017,33(12):1243-1248.
[17]	KURIAKOSE T,KANNEGANTI T D.Regulation and functions of NLRP3 inflammasome during influenza virus infection[J]. Mol Immunol,2017,86:56-64.
[18]	WANG B,LAM T H,SOH M K,et al.Influenza A virus facilitates its infectivity by activating p53 to inhibit the expression of interferon-induced transmembrane proteins[J]. Front Immunol,2018,9:1193.
[19]	SEONG M W,CHO S I,PARK H,et al.Genotyping influenza virus by next-generation deep sequencing in clinical specimens[J]. Ann Lab Med,2016,36(3):255-258.
[20]	VEMULA S V,ZHAO J,LIU J,et al.Current approaches for diagnosis of influenza virus infections in humans[J]. Viruses,2016,8(4):96.
[21]	KRITTANAI S,KITISRIPANYA T,UDOMSIN O,et al.Development of a colloidal gold nanoparticle-based immunochromatographic strip for the one-step detection of miroestrol and puerarin[J]. Biomed Chromatogr,2018,32(11):e4330.
[22]	ZHAO J,LIU J,VEMULA S V,et al.Sensitive detection and simultaneous discrimination of influenza A and B viruses in nasopharyngeal swabs in a single assay using next-generation sequencing-based diagnostics[J]. PLoS One,2016,11(9):e0163175.
[23]	LEE H K,LEE C K,TANG J W T,et al. Contamination-controlled high-throughput whole genome sequencing for influenza A viruses using the MiSeq sequencer[J]. Sci Rep,2016,6:33318.
[24]	SHEN K M,SABBAVARAPU N M,FU C Y,et al.An integrated microfluidic system for rapid detection and multiple subtyping of influenza A viruses by using glycan-coated magnetic beads and RT-PCR[J]. Lab Chip,2019,19(7):1277-1286.
[25]	LU P H,MA Y D,FU C Y,et al.A structure-free digital microfluidic platform for detection of influenza a virus by using magnetic beads and electromagnetic forces[J]. Lab Chip,2020,20(4):789-797.
[26]	KATZEN J,KOHN R,HOUK J L,et al.Early oseltamivir after hospital admission is associated with shortened hospitalization:a 5-year analysis of oseltamivir timing and clinical outcomes[J]. Clin Infect Dis,2019,69(1):52-58.
[27]	JIA X,LIU B,BAO L,et al.Delayed oseltamivir plus sirolimus treatment attenuates H1N1 virus-induced severe lung injury correlated with repressed NLRP3 inflammasome activation and inflammatory cell infiltration[J]. PLoS Pathog,2018,14(11):e1007428.
[28]	CHEN J Y,WEI S K,LAI C C,et al.A Meta-analysis comparing the efficacy and safety of peramivir with other neuraminidase inhibitors for influenza treatment[J]. Medicina(Kaunas),2020,56(2):63.
[29]	SCOTT L J.Correction to:peramivir:a review in uncomplicated influenza[J]. Drugs,2018,78( 14 ):1525.
[30]	WANG P C,CHIU D C,JAN J T,et al.Peramivir conjugates as orally available agents against influenza H 275Y mutant[J]. Eur J Med Chem,2018,145:224-234 .
[31]	OH D Y,PANOZZO J,VITESNIK S,et al.Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets[J]. Antivir T her,2018,23( 4):295-306 .
[32]	NOSHI T,KITANO M,TANIGUCHI K,et al.In vitro characterization of baloxavir acid,a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit[J]. Antiviral Res,2018,160:109-117.
[33]	HAYDEN F G,SUGAYA N,HIROTSU N,et al.Baloxavir marboxil for uncomplicated influenza in adults and adolescents[J]. N Engl J Med,2018,379(10):913-923.
[34]	世界卫生组织,季节性流感[EB/OL](2018-03-31)[2020-02-20]. .
[35]	罗剑,李秀玲. 基于细胞培养的流感疫苗研究进展[J]. 中国新药杂志,2019,28(21):2594-2599.
[36]	李文娟,王大燕. 我国流感疾病负担相关研究进展[J]. 中国人兽共患病学报,2019,35(10):928-933.
[37]	SHAHAM A,CHODICK G,SHALEV V,et al.Personal and social patterns predict influenza vaccination decision[J]. BMC Public Health,2020,20(1):222.

流感病毒研究现状与进展

Research status and progress of influenza viruses

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 37

相关文章 15

编辑推荐

Metrics

[1]	孙泽朋, 王洪彬, 王建东, 宋德伟, 肖鹏. 心肌损伤多肽和蛋白类标志物方法学分析和进展[J]. 检验医学, 2023, 38(8): 784-789.
[2]	陈丹阳, 郑思钰, 郑锐林, 苏静瑶, 朱冰, 李英华. 流感病毒研究进展[J]. 检验医学, 2023, 38(7): 696-703.
[3]	李卫滨, 李瑞斌, 张胜行. 新型冠状病毒变异株生物学特性及其检测方法[J]. 检验医学, 2023, 38(4): 394-398.
[4]	李文静, 陆书华, 李晓哲, 戈宁宁, 董海新. 非O1/非O139群霍乱弧菌血流感染病原学和临床特征[J]. 检验医学, 2023, 38(12): 1191-1194.
[5]	刘世芸, 檀平. 2018—2019年池州市流行性感冒病原学分析[J]. 检验医学, 2021, 36(7): 722-725.
[6]	唐钧, 曹红梅. 甲型H1N1流感病毒RNA检测方法的建立及临床应用[J]. 检验医学, 2021, 36(7): 738-742.
[7]	高东田, 刘利华, 申爱华, 孙寅. 侵袭性肺曲霉菌感染实验诊断新进展[J]. 检验医学, 2021, 36(4): 453-461.
[8]	李丽, 周敏, 乔丹, 朱咏臻, 韩立中. 恶性血液病患者继发感染病原菌分布及其耐药性分析[J]. 检验医学, 2020, 35(3): 189-194.
[9]	赖媛媛, 王宇婷, 陈家倪, 齐军, 何振业. SARS-CoV-2病原学特点、实验室检测及实验室生物安全防护[J]. 检验医学, 2020, 35(3): 278-281.
[10]	付晓蕊, 康蓓佩, 徐修礼, 赵峰, 张鹏亮, 周磊. 快速病原体检测技术在甲型流感病毒检测中的应用[J]. 检验医学, 2020, 35(11): 1165-1168.
[11]	周宏伟, 胡燕燕, 张嵘. 碳青霉烯类耐药肠杆菌科细菌的检测方法[J]. 检验医学, 2020, 35(10): 971-973.
[12]	孙召洋, 刘文健, 张景皓, 方毅, 赵虎, 张艳梅. 泌尿系统感染检测方法研究进展[J]. 检验医学, 2019, 34(12): 1133-1138.
[13]	池细俤, 高世华, 李国玉, 吴文辉. 人型支原体致手术切口感染临床特征[J]. 检验医学, 2018, 33(9): 859-861.
[14]	张旭. EB病毒检测及其临床应用的研究进展[J]. 检验医学, 2018, 33(3): 259-263.
[15]	赵虎, 张景皓, 张艳梅. 非经典微生物感染的病原学诊断及其耐药性分析[J]. 检验医学, 2018, 33(12): 1063-1066.